Authors:

Floria Eva, Gusti Ayu Putu Nilawati

Abstract:

“Rapidly progressive glomerulonephritis (RPGN) is a rare syndrome in children and one of the nephrologyemergency which needs special attention. Rapidly progressive glomerulonephritis is determined bysymptoms and signs of glomerulonephritis (GN); edema, hypertension, gross hematuria, and rapid lossof renal function. Early diagnosis and appropriate treatment play a critical role in saving renal functionand preventing permanent glomerular damage. Diagnosis was made based on clinical and laboratoryfindings. We reported two cases of RPGN in an eleven year old boy and an eight year old boy. The patientcame to the pediatric outpatient clinic at sanglah hospital with chief complaint dark ?cola colored?urine. Laboratory work up showed proteinuria, erythrocyturia, decrease of C3 and normal C4 complementlevel, increased serum urea and creatinine level and loss of renal function in a few days with glomerularfiltration rate decreased. Based on clinical and laboratory findings, the patient was diagnosed asrapidly progressive glomerulonephritis. The patient was given methylprednisolone pulses for 3 days,followed by high dose oral methylprednisolone. Prognosis of the patient was good. [MEDICINA2015;46:46-51].”

Keywords

Keyword Not Available

Downloads:

Download data is not yet available.

References

References Not Available

PDF:

https://jurnal.harianregional.com/medicina/full-15980

Published

2021-11-09

How To Cite

EVA, Floria; NILAWATI, Gusti Ayu Putu. RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS IN CHILDREN.Medicina, [S.l.], v. 46, n. 1, oct. 2015. ISSN 2540-8321. Available at: https://jurnal.harianregional.com/medicina/id-15980. Date accessed: 02 Jun. 2025.

Citation Format

ABNT, APA, BibTeX, CBE, EndNote - EndNote format (Macintosh & Windows), MLA, ProCite - RIS format (Macintosh & Windows), RefWorks, Reference Manager - RIS format (Windows only), Turabian

Issue

Vol 46 No 1 (2015): Januari 2015

Section

Articles

Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License